NEW YORK (GenomeWeb News) – OriGene Technologies has acquired Marligen Biosciences, a privately held seller of DNA and RNA purification kits and multiplex assays for genotyping, microRNA profiling, and transcription factor activity analysis.

Rockville, Md.-based OriGene makes gene cloning and gene expression tools. OriGene raised $6.5 million earlier this year in a private equity financing to support its acquisition of Shenzhen P&A Biotech, a manufacturer of monoclonal antibodies.

The firms did not disclose the purchase price.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec
04
Sponsored by
Sophia Genetics

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.